Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2014 Oct 2;55:89–106. doi: 10.1146/annurev-pharmtox-010814-124835

Table 1.

Summary of the genotyping platform used by 5 U.S. institutions to implement array-based preemptive pharmacogenetic testing

Institution Genotyping platform Number of genes assayed
Mayo Clinic (43) PGRN-Seq 84
Mount Sinai Medical Center (42) PGRN-Seq 84
St. Jude Children's Research Hospital (65) Affymetrix DMET Plus array 230
University of Florida and Shands Hospital (35) Life Technologies Quant Studio Open Array 120
Vanderbilt University Medical Center (69) VeraCode ADME Core Panel 34